He's the best physician that knows the worthlessness of the most medicines - Benjamin Franklin


image by: American Society of Clinical Oncology

HWN Recommends

Will These Hurdles Cripple Precision Medicine?

As a practicing oncologist with several years of experience, I am excited and amazed by the rapid advances we are making in precision medicine. Since the FDA approved imatinib (Gleevec) for the treatment of chronic myeloid leukemia in 2001, targeted treatments for patients with specific genetic mutations along with advances in immunotherapy have been the most significant developments in cancer treatment. However, the advances in technology, genomic analysis, and precision medicine treatments are outpacing current medical education, clinical services, and clinical research programs.

One of the barriers to precision medicine stems from the fact that many physicians did not receive training…

read full article


Stay Connected

©2020 | HealthWorldNet, Inc. | 108320

Last Updated : Wednesday, June 17, 2020